Infrared and AI combine for new brain tumour blood test

News

Researchers at the University of Strathclyde have developed a new blood test for brain tumours that can accurately detect cancer with 87 per cent accuracy.

brain tumour

Symptoms associated with brain tumours such as headache and memory inhibition are non-specific, making it difficult to diagnose the cancer. The new patented technique uses attenuated total reflection- Fourier transform infrared (ATR-FTIR) spectroscopy, in combination with artificial intelligence, to rapidly diagnose the condition in triage conditions.

Synapse-mapping chip gives new picture of brain activity

Artificial nose sniffs surgical smoke to identify brain tumours

The technology has been developed by ClinSpec Diagnostics, which was spun out from the University in February 2019. According to a paper based on the work published in Nature Communications, the blood test can characterise the biochemical profile of a sample without extensive sample preparation

“This is the first publication of data from our clinical feasibility study and it is the first demonstration that our blood test works in the clinic,” said research lead Dr Matthew Baker, chief scientific officer at ClinSpec Diagnostics and reader in Strathclyde’s Department of Pure and Applied Chemistry.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox

Register
Or continue by

Signing in with your registered email address